The role of Bemitil pharmacokinetics in realizing its therapeutic efficacy
S. S. Boiko, V. P. Zherdev, G. G. Neznamov · 1991 · Farmakol Toksikol. 54(2):64–66. PMID 1679400
What does this source report?
Reports correlations between selected pharmacokinetic parameters and overall clinical response.
- Population and setting
- Patients with asthenoneurotic disturbances, including monotherapy and phenazepam combination contexts
- Evidence type
- Uncontrolled human report
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Does not validate a safe combination, dosing schedule or general interaction rule.
- Sample size and underlying statistical analyses need full-text review.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed citation and abstract checked; full methods and risk of bias remain unreviewed.
Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.
Cite and trace this record
Original source: S. S. Boiko, V. P. Zherdev, G. G. Neznamov. The role of Bemitil pharmacokinetics in realizing its therapeutic efficacy Farmakol Toksikol. 54(2):64–66. PMID 1679400 1991.
Molekul research summary: https://molekul.io/research/acto-1679400. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry